Skip to main content

Table 1 Percentages of benign and malignant lesions in the study population according to histopathology

From: Added value of contrast-enhanced spectral mammography in symptomatic patients with dense breasts

  No. = 25
Benign or malignant
 Benign 11 (44.0%)
 Malignant 14 (56.0%)
Histopathology
 No abnormality 1 (4.0%)
 IDC 13 (52.0%)
 Fibroadenoma 5 (20.0%)
 Lobular mastitis 2 (8.0%)
 Lobular carcinoma 1 (4.0%)
 Fibroadenosis 1 (4.0%)
 Fibrocystic disease 1 (4.0%)
 Diabetic mastopathy 1 (4.0%)